We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Newcleo Stock

Invest in or calculate the value of your shares in Newcleo or other pre-IPO companies through EquityZen's platform.

Get Started

Newcleo Stock

Newcleo is an atomic energy company that focuses on developing advanced nuclear energy technologies.

About Newcleo Stock

Founded

2021

Industries

Software, Artificial Intelligence, Data and Analytics

Newcleo is a clean energy company focused on revolutionizing nuclear power through innovative technologies. Newcleo is developing small modular reactors (SMRs) based on Lead-Cooled Fast Reactor (LFR) technology, which offers a more stable cooling mechanism and higher safety margins compared to traditional reactors. LFRs use lead as a coolant instead of water, eliminating the risk of steam explosions and enhancing reactor safety. In addition to this advanced cooling system, Newcleo employs a closed fuel cycle approach that emphasizes recycling nuclear waste as fuel for their reactors. This strategy not only reduces the need for new uranium mining but also helps address the challenge of long-term radioactive waste disposal by repurposing existing waste. Newcleo aims to create safe and clean energy solutions by reprocessing nuclear fuel, offering a renewable alternative in the energy sector.

Newcleo Management

Leadership team at Newcleo

Chief Scientific Officer and Co-Founder

Luciano Cinotti

Group Chief Financial Officer

Jon Stranske

Locked Features

Join now and verify your accreditation status to gain access to:

  • Newcleo Current Valuation
  • Newcleo Stock Price
  • Newcleo Management
  • Available deals in Newcleo and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Newcleo Cap Table and Funding History by Share Class and Liquidity Preferences
    • Newcleo Revenue and Financials
    • Newcleo Highlights
    • Newcleo Business Model
    • Newcleo Risk Factors
  • Newcleo Research Report from SACRA Research
Join Now

Trading Newcleo Stock

How to invest in Newcleo stock?

Accredited investors can buy pre-IPO stock in companies like Newcleo through EquityZen funds. These investments are made available by existing Newcleo shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell Newcleo stock?

Shareholders can sell their Newcleo stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Newcleo